[raccoonradio]

From Comm. Of Mass:
Monoclonal antibody therapy (mAb) is a promising option for higher-risk patients who have tested positive for COVID-19 or who have been exposed to someone with COVID-19. Higher-risk patients may be older or have a medical condition. When given in a timely manner, mAb has been shown to be effective in reducing the severity of disease and keeping COVID-19-positive patients out of the hospital.

---

Kuhner is 52 y.o. and I don’t know if he
has co-morbidities like diabetes....

[Lovely-Day-For-A-Guinness]

He's admitted to being a diabetic, as I recall

Sandy also said he took ivermectin.

Maybe it's time to ping all the vaxholes to alert them of this.

[Sparky1776]

Yes, Jeff has Type II. Hope he gets better soon.

[icclearly]

“Monoclonal antibody therapy (mAb) is a promising option for higher-risk patients”

mAb’s don’t normally kill people or cause life-altering conditions. Why should it be restricted to high-risk?